JESSA MIGNON SUHNER
NEW YORK, NY
Browse related groups: NY Karyopharm Therapeutics Inc. All categories
This page merges CMS profile IDs: 11308307, 11311338 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$598.20
- Category: General Payments
- Program years: PY2021–2024
- Record count: 17
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $237.71 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $237.71 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Karyopharm Therapeutics Inc. | $73.50 | 1 |
| Genmab U.S., Inc. | $55.36 | 2 |
| Medical Device Business Services, Inc. | $40.46 | 1 |
| EISAI INC. | $18.78 | 1 |
| Merck Sharp & Dohme Corporation | $17.47 | 1 |
| GlaxoSmithKline, LLC. | $16.43 | 1 |
| Solventum Corporation | $15.71 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1077808575 | Medical Device Business Services, Inc. | $40.46 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110752592 | Eisai Inc. | $18.78 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116555967 | GlaxoSmithKline, LLC. | $16.43 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1126827712 | Genmab U.S., Inc. | $25.60 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1126827714 | Genmab U.S., Inc. | $29.76 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141829232 | Merck Sharp & Dohme LLC | $17.47 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144076292 | Solventum Corporation | $15.71 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145531358 | Karyopharm Therapeutics Inc. | $73.50 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs: 11308307, 11311338
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.